Advertisement
CHD vs CL
Which Stock Would AI Choose? Church & Dwight (CHD) vs. Colgate-Palmolive (CL) Stock Comparison
Key Takeaways
- CHD has outperformed the broader market year-to-date, driven by resilient brand momentum and a focus on faster-growing personal care categories.
- CL offers greater scale, global diversification, and a higher dividend yield, but faces softer growth in its North America segment.
- Both companies are defensive consumer staples, yet their growth profiles differ meaningfully: CHD skews toward U.S. household and personal care, while CL derives most of its revenue from international markets.
- Valuation is elevated for both stocks, with forward price-to-earnings multiples in the low-to-mid 20s, leaving limited room for multiple expansion.
- Relative performance in recent weeks has favored CHD, although CL's brand-restructuring efforts could act as a near-term catalyst.
Introduction
Church & Dwight Co., Inc. (CHD) and Colgate-Palmolive Company (CL) are two of the most recognizable names in household and personal care. Both operate in the defensive consumer staples sector, selling everyday products that generate stable, recurring demand regardless of economic conditions. This stock comparison is particularly relevant for investors weighing quality consumer franchises with different growth engines, geographic exposures, and capital-return profiles. Income-focused investors may favor CL's higher yield, while growth-oriented investors may be drawn to CHD's faster organic expansion. Understanding their relative performance and market positioning can help traders and long-term investors assess which name aligns better with current market conditions.
CHD Overview and Recent Performance
Church & Dwight is a diversified consumer products company best known for its ARM & HAMMER brand, alongside a portfolio that includes THERABREATH oral care, HERO skincare, TROJAN, and the recently acquired TOUCHLAND hand sanitizer brand. The company generates roughly $6.2 billion in annual revenue and has built a reputation for reliable organic growth through innovation and targeted acquisitions.
In recent weeks, CHD shares have traded near the $94 level, with a 52-week range between roughly $81 and $106. The stock's beta of approximately 0.47 reflects its defensive, low-volatility character. Year-to-date, CHD has meaningfully outperformed the S&P 500, supported by better-than-expected earnings and resilient consumer demand. Management's 2026 guidance calls for adjusted earnings per share growth of about 5% to 8% and volume-driven organic sales growth of approximately 3% to 4%. Key drivers include expansion of ARM & HAMMER, growth of the THERABREATH oral care line, and international growth. Headwinds include elevated marketing investment, persistent inflation, and tariff-related cost pressures, as well as the prior exit from the vitamins business.
CL Overview and Recent Performance
Colgate-Palmolive is a global leader in oral care, holding roughly 41% of the worldwide toothpaste market and about 33% of the manual toothbrush market. Its portfolio spans oral care, personal care, home care, and the Hill's Pet Nutrition business. With annual revenue exceeding $20 billion, CL is significantly larger than CHD and generates a substantial majority of its sales outside the United States.
In recent weeks, CL shares have traded near the $84 level, within a 52-week range of approximately $74 to $99. The company has delivered consistent organic sales growth, most recently posting mid-single-digit gains in several quarters, driven by strength in emerging markets such as India, Brazil, and Mexico. However, North America has been its weakest region, weighed down by softer volumes and competitive pressure. CL has also announced plans to explore the sale of certain mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, signaling a portfolio simplification strategy. As a Dividend King, CL has raised its dividend for more than six decades and currently offers a yield near 2.5%.
Trending AI Robots
For traders seeking a data-driven edge in this type of stock comparison, Tickeron's Trending AI Robots page offers a curated view of its strongest-performing automated strategies. Tickeron hosts hundreds of AI Trading Bots that collectively trade thousands of different tickers, but only those best suited to current market conditions earn a place in this featured section. These bots vary widely in trading style, strategy, timeframe, performance history, and the specific sets of tickers they follow, allowing users to match a bot's approach to their own risk tolerance and objectives. Exploring the Trending AI Robots page can help investors see how systematic, AI-driven analysis currently ranks names like CHD and CL relative to the broader market.
Head-to-Head Comparison
Although both companies operate in consumer staples, their business models and growth drivers diverge in important ways. CHD is a domestic-focused growth story built on innovation and bolt-on acquisitions, with a leaner portfolio concentrated in high-margin household and personal care niches. Its recent momentum reflects successful new product launches and steady gross-margin expansion. CL, by contrast, is a global scale player whose results hinge more on emerging-market demand, currency movements, and category leadership in oral care.
From a risk standpoint, CHD carries more exposure to U.S. consumer spending and rising marketing costs, while CL faces currency volatility, geopolitical risk across its many markets, and a challenged North American business. On valuation, both trade at premium multiples: CHD's forward price-to-earnings ratio sits in the low-to-mid 20s, and CL's is comparable, leaving little cushion if growth disappoints. In terms of income, CL's higher dividend yield and lengthy dividend-growth history give it an edge for income-oriented investors, whereas CHD's faster organic growth and stronger recent relative performance may appeal to those prioritizing momentum.
Tickeron AI Verdict
Based on observable trend consistency, relative momentum, and near-term catalysts, Tickeron's AI framework would likely lean toward CHD in the current environment. CHD has demonstrated steadier upward price momentum and stronger year-to-date relative performance, backed by consistent organic growth and margin expansion. CL's global scale and dependable dividend remain compelling, but softer North American volumes and portfolio restructuring introduce greater near-term uncertainty. This probabilistic view does not constitute a prediction, and both stocks carry meaningful valuation risk at current levels.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHD is a Buy and CL is a Buy.
CHD's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for CHD turned positive on October 05, 2026. Looking at past instances where CHD's MACD turned positive, the stock continued to rise in 28 of 50 cases over the following month. The odds of a continued upward trend are 56%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on CHD as a result. In 46 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 49%.
CHD moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CHD crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 38%.
Following a +4.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHD advanced for three days, in 166 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.
The Aroon Indicator entered an Uptrend today. In 88 of 217 cases where CHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 41%.
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.
CHD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 16 (best 1 - 100 worst), indicating outstanding price growth. CHD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.112) is normal, around the industry mean (21.072). P/E Ratio (35.792) is within average values for comparable stocks, (16.552). Projected Growth (PEG Ratio) (2.688) is also within normal values, averaging (1.518). Dividend Yield (0.011) settles around the average of (0.033) among similar stocks. P/S Ratio (3.676) is also within normal values, averaging (1.902).
CL's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for CL turned positive on October 06, 2026. Looking at past instances where CL's MACD turned positive, the stock continued to rise in 27 of 43 cases over the following month. The odds of a continued upward trend are 63%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on CL as a result. In 33 of 68 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 49%.
CL moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CL crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +4.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where CL advanced for three days, in 145 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.
The Aroon Indicator entered an Uptrend today. In 118 of 277 cases where CL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 43%.
Bearish Trend Analysis
The 10-day RSI Indicator for CL moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 13 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 34%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.
CL broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 21 (best 1 - 100 worst), indicating outstanding price growth. CL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CL's P/B Ratio (333.597) is very high in comparison to the industry average of (21.072). P/E Ratio (38.882) is within average values for comparable stocks, (16.552). Projected Growth (PEG Ratio) (1.577) is also within normal values, averaging (1.518). Dividend Yield (0.021) settles around the average of (0.033) among similar stocks. P/S Ratio (3.331) is also within normal values, averaging (1.902).
CHD | CL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 44 | 30 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 42 | 42 | |
SMR RATING 1..100 | 52 | 8 | |
PRICE GROWTH RATING 1..100 | 16 | 21 | |
P/E GROWTH RATING 1..100 | 18 | 6 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CHD's Valuation (85) in the Household Or Personal Care industry is in the same range as CL (99). This means that CHD’s stock grew similarly to CL’s over the last 12 months.
CHD's Profit vs Risk Rating (42) in the Household Or Personal Care industry is in the same range as CL (42). This means that CHD’s stock grew similarly to CL’s over the last 12 months.
CL's SMR Rating (8) in the Household Or Personal Care industry is somewhat better than the same rating for CHD (52). This means that CL’s stock grew somewhat faster than CHD’s over the last 12 months.
CHD's Price Growth Rating (16) in the Household Or Personal Care industry is in the same range as CL (21). This means that CHD’s stock grew similarly to CL’s over the last 12 months.
CL's P/E Growth Rating (6) in the Household Or Personal Care industry is in the same range as CHD (18). This means that CL’s stock grew similarly to CHD’s over the last 12 months.
| CHD | CL | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 53% | 1 day ago 34% |
| Stochastic ODDS (%) | 1 day ago 46% | 1 day ago 32% |
| Momentum ODDS (%) | 1 day ago 49% | 1 day ago 49% |
| MACD ODDS (%) | 1 day ago 56% | 1 day ago 63% |
| TrendWeek ODDS (%) | 1 day ago 50% | 1 day ago 50% |
| TrendMonth ODDS (%) | 1 day ago 47% | 1 day ago 50% |
| Advances ODDS (%) | 4 days ago 49% | 4 days ago 46% |
| Declines ODDS (%) | 9 days ago 48% | 9 days ago 47% |
| BollingerBands ODDS (%) | 1 day ago 53% | 1 day ago 41% |
| Aroon ODDS (%) | 1 day ago 41% | 1 day ago 43% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CHD’s FA Score shows that 2 FA rating(s) are green while CL’s FA Score has 3 green FA rating(s).
- CHD’s FA Score: 2 green, 3 red.
- CL’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CHD’s TA Score shows that 6 TA indicator(s) are bullish while CL’s TA Score has 6 bullish TA indicator(s).
- CHD’s TA Score: 6 bullish, 4 bearish.
- CL’s TA Score: 6 bullish, 4 bearish.
Price Growth
CHD (@Household/Personal Care) experienced а +6.95% price change this week, while CL (@Household/Personal Care) price change was +7.71% for the same time period.
The average weekly price growth across all stocks in the @Household/Personal Care industry was +4.44%. For the same industry, the average monthly price growth was +5.18%, and the average quarterly price growth was +13.59%.
Reported Earning Dates
CHD is expected to report earnings on Jan 29, 2027.
CL is expected to report earnings on Jan 22, 2027.
Industries' Descriptions
@Household/Personal Care (+4.44% weekly)Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.
Advertisement
CHD and
Correlation & Price change
A.I.dvisor indicates that over the last year, CHD has been closely correlated with CL. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if CHD jumps, then CL could also see price increases.
CL and
Correlation & Price change
A.I.dvisor indicates that over the last year, CL has been closely correlated with PG. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CL jumps, then PG could also see price increases.